Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus

American Journal of Gastroenterology

Volumn 97, Issue 8, 2002, Pages 2086-2092

  Miyazoe, Seiji ^a   Hamasaki, Keisuke ^a   Nakata, Keisuke ^a   Kajiya, Yuji ^a   Kitajima, Kayo ^a   Nakao, Kazuhiko ^a   Daikoku, Manabu ^b   Yatsuhashi, Hiroshi ^b   Koga, Michiaki ^b   Yano, Michitami ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELISM; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; JAPAN; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEROPREVALENCE; VIRUS PATHOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-10; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036678924     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04283-1     Document Type: Article

References (39)

1. Hepatitis B virus infection
2. Protective efficacy of hepatitis B vaccines in neonates
3. e Antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants
4. Vertical transmission of hepatitis B antigen in Taiwan
5. Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan
6. Vaccination of infants and children against hepatitis B
7. Noncytolytic control of viral infections by the innate and adaptive immune response
8. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: A clinical and histologic evaluation of 242 cases
9. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal
10. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B
11. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections
12. A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus
13. Hepatitis B virus markers in Chinese twins
14. Class II HLA alleles and hepatitis B virus persistence in African Americans
15. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B
16. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
17. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
18. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
19. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways
20. Hepatitis B virusspecific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha
21. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
22. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
23. Properties and functions of interleukin-10
24. Genetic influence on cytokine production in meningococcal disease
25. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)alpha gene in Japanese
26. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter
27. An investigation of polymorphism in the interleukin-10 gene promoter
28. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
29. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
30. An algorithm for the grading of activity in chronic hepatitis C
31. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
32. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
33. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection
34. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population
35. Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy
36. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection
37. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
38. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis
39. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro